AIRS
SinkerAirSculpt Technologies, Inc. · Healthcare · United States · $87M cap · $988K/day traded
$0.7201 -10.7% · close 12 Nov · scored 13 Nov
Sinker: Weak business, rich price and weak momentum. Nothing here to keep it afloat.
As of 13 Nov 2026, the MoatMap Score for AirSculpt Technologies, Inc. (AIRS) is 21/100, ranked against 25,000+ stocks in 38 markets (Quality 41, Value 43, Momentum 22, each scored against its sector).
Does the score work? Each tenth of the ranking, tracked monthly. See the record →
ABOUT AIRSCULPT TECHNOLOGIES, INC.
Read
AirSculpt Technologies, Inc. operates a network of body contouring and fat removal centers, utilizing its proprietary AirSculpt technology for minimally invasive procedures. The company benefits from its unique, patented AirSculpt technology, offering a distinct and less invasive alternative to traditional liposuction, leading to high patient satisfaction. It is a specialized healthcare services provider with a focus on aesthetic procedures, leveraging its proprietary technology and a direct-to-consumer marketing model.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 133.3M | 168.8M | 195.9M | 180.3M | 151.8M | 3.3% | 150.7M | 147.8M | 149.1M | -0.9% |
| EPS | -0.01 | -0.26 | -0.08 | -0.14 | -0.19 | — | -0.12 | -0.20 | -0.11 | — |
| Shares | 55.6M | 56.2M | 57.4M | 58.4M | 64.5M | +16.0% | 72.1M | — | — | — |
| Debt | 100.6M | 107.6M | 99.7M | 108.9M | 83.6M | -4.5% | 70.5M | — | — | — |
| Equity | 83.5M | 70.8M | 84.0M | 78.2M | 87.7M | 1.2% | — | — | — | — |
| Op CF | 26.6M | 24.4M | 24.0M | 11.3M | 3.1M | -41.6% | 1.3M | — | — | — |
| Inv CF | -7.1M | -12.9M | -9.9M | -14.0M | -2.4M | — | — | — | — | — |
| Fin CF | -4.5M | -27.3M | -13.4M | 0.6M | -0.5M | — | — | — | — | — |
Made a new 52-week low 4 trading days ago, 88% below its 52-week high. The fall has not stopped yet.
Swung more than 99% of stocks we rank over the past year (volatility 141% a year).
How this is worked out
The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.
- Still falling (this stock): It set a new 52-week low in the last two weeks, after a deep fall.
- Finding a floor: It fell hard, but has set no new low for more than two weeks.
- Turning up: It has climbed off its low and is back above a rising 50-day average.
- In an uptrend: It is near its 52-week high and above its 200-day average.
- No clear trend: None of the above: no recent deep fall and no steady climb.
- No read yet: Not enough price history yet: it needs a year of trading.
In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.
The exact rules
Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AIRS are excluded.
| Ticker | Company | Mkt Cap | Score |
|---|---|---|---|
| AIRS | AirSculpt Technologies, Inc.(you) | $87M | 21 |
| DCGO | DocGo Inc. | $59M | 21 |
| PARK | Park Dental Partners, Inc. | $94M | 53 |
| JYNT | The Joint Corp. | $102M | 70 |
| STLN | The Oncology Institute, Inc. | $684M | 33 |
| BTMD | biote Corp. | $53M | 66 |
| SRTA | Strata Critical Medical, Inc. | $412M | 45 |
| PIII | P3 Health Partners Inc. | $844M | 10 |
| WW | WW International, Inc. | $135M | 72 |
| BKD | Brookdale Senior Living Inc. | $2.4B | 21 |
Peer medians: ROE -31.0% · P/E 25.9x · Gross margin 62.7%
Company Deep Dive
A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.